Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $28 | $30 | $40 |
| Short-Term Investments | $97 | $114 | $136 | $145 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $7 | $4 | $3 |
| Total Curr. Assets | $130 | $149 | $170 | $189 |
| Property Plant & Equip (Net) | $18 | $20 | $21 | $20 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $19 | $20 | $21 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $149 | $169 | $191 | $210 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $1 |
| Short-Term Debt | $3 | $4 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $6 | $6 | $7 |
| Total Curr. Liab. | $11 | $11 | $12 | $12 |
| LT Debt | $9 | $10 | $10 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9 | $10 | $10 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $13 | $14 | $14 |
| Total Liabilities | $20 | $20 | $22 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$310 | -$288 | -$267 | -$247 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $439 | $437 | $436 | $433 |
| Total Equity | $129 | $149 | $169 | $187 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $149 | $169 | $191 | $210 |
| Net Debt | -$14 | -$15 | -$16 | -$26 |